Amylyx Pharmaceuticals, Inc. (AMLX)

13.88 -0.22 (-1.60%) USD  |  NASDAQ  |  Mar 06, 16:00
13.88 0.00 (0.00%) After-Hours: 19:51
More

Amylyx Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Rapt Therapeutics, Inc. --
Disc Medicine, Inc. --
Cytokinetics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MediciNova, Inc. Upgrade